Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04655976 |
|---|---|
| Brief Title: | Efficacy Comparison of Cobolimab + Dostarlimab + Docetaxel to Dostarlimab + Docetaxel to Docetaxel Alone in Participants With Advanced Non-Small Cell Lung Cancer Who Have Progressed on Prior Anti- Programmed Death-ligand 1 (PD-[L]1) Therapy and Chemotherapy (COSTAR Lung) |
| First Submitted : | November 30, 2020 |
| First Submitted that Met QC Criteria : | November 30, 2020 |
| First Posted : | December 7, 2020 |
| Last Update Submitted that Met QC Criteria : | February 18, 2024 |
| Last Update Posted : | February 20, 2024 |